Keywords: Alzheimer's disease, R&D pipelines, PhRMA, USA, Research obstacles, Successes

Alzheimer's disease: From setbacks to stepping stones

Article | 16 September 2012

The Pharmaceutical Research and Manufacturers of America (PhRMA) last week released two new reports at its first annual Research and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in